Frontiers in Cell and Developmental Biology (May 2023)
Loss of the matrix metalloproteinase-10 causes premature features of aging in satellite cells
- Miriam Bobadilla Muñoz,
- Miriam Bobadilla Muñoz,
- Josune Orbe,
- Josune Orbe,
- Josune Orbe,
- Gloria Abizanda,
- Gloria Abizanda,
- Florencio J. D. Machado,
- Florencio J. D. Machado,
- Amaia Vilas,
- Amaia Vilas,
- Asier Ullate-Agote,
- Asier Ullate-Agote,
- Leire Extramiana,
- Leire Extramiana,
- Arantxa Baraibar Churio,
- Arantxa Baraibar Churio,
- Xabier L. Aranguren,
- Xabier L. Aranguren,
- Gloria Cantero,
- Gloria Cantero,
- Neira Sáinz Amillo,
- Neira Sáinz Amillo,
- José Antonio Rodríguez,
- José Antonio Rodríguez,
- José Antonio Rodríguez,
- Luis Ramos García,
- Luis Ramos García,
- Juan Pablo Romero Riojas,
- Juan Pablo Romero Riojas,
- Ainara Vallejo-Illarramendi,
- Carmen Paradas,
- Carmen Paradas,
- Adolfo López de Munain,
- Adolfo López de Munain,
- José Antonio Páramo,
- José Antonio Páramo,
- José Antonio Páramo,
- José Antonio Páramo,
- Felipe Prósper,
- Felipe Prósper,
- Felipe Prósper,
- Ana Pérez-Ruiz,
- Ana Pérez-Ruiz
Affiliations
- Miriam Bobadilla Muñoz
- Regenerative Medicine Program, Center for Applied Medical Research (CIMA) Universidad de Navarra, CIBERONC, Madrid, Spain
- Miriam Bobadilla Muñoz
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- Josune Orbe
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- Josune Orbe
- Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, CIMA Universidad de Navarra, Pamplona, Spain
- Josune Orbe
- Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS)-Ictus, Instituto de Salud Carlos III, Madrid, Spain
- Gloria Abizanda
- Regenerative Medicine Program, Center for Applied Medical Research (CIMA) Universidad de Navarra, CIBERONC, Madrid, Spain
- Gloria Abizanda
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- Florencio J. D. Machado
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- Florencio J. D. Machado
- Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, CIMA Universidad de Navarra, Pamplona, Spain
- Amaia Vilas
- Regenerative Medicine Program, Center for Applied Medical Research (CIMA) Universidad de Navarra, CIBERONC, Madrid, Spain
- Amaia Vilas
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- Asier Ullate-Agote
- Regenerative Medicine Program, Center for Applied Medical Research (CIMA) Universidad de Navarra, CIBERONC, Madrid, Spain
- Asier Ullate-Agote
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- Leire Extramiana
- Regenerative Medicine Program, Center for Applied Medical Research (CIMA) Universidad de Navarra, CIBERONC, Madrid, Spain
- Leire Extramiana
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- Arantxa Baraibar Churio
- Regenerative Medicine Program, Center for Applied Medical Research (CIMA) Universidad de Navarra, CIBERONC, Madrid, Spain
- Arantxa Baraibar Churio
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- Xabier L. Aranguren
- Regenerative Medicine Program, Center for Applied Medical Research (CIMA) Universidad de Navarra, CIBERONC, Madrid, Spain
- Xabier L. Aranguren
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- Gloria Cantero
- Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Neuromuscular Disorders Unit, Sevilla, Spain
- Gloria Cantero
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
- Neira Sáinz Amillo
- Regenerative Medicine Program, Center for Applied Medical Research (CIMA) Universidad de Navarra, CIBERONC, Madrid, Spain
- Neira Sáinz Amillo
- Centre for Nutrition Research, Universidad de Navarra, Pamplona, Spain
- José Antonio Rodríguez
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- José Antonio Rodríguez
- Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, CIMA Universidad de Navarra, Pamplona, Spain
- José Antonio Rodríguez
- Centro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain
- Luis Ramos García
- Radiology Department, Clínica Universidad de Navarra, Pamplona, Spain
- Luis Ramos García
- 0Radiology Department, Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, San Sebastian, Spain
- Juan Pablo Romero Riojas
- Regenerative Medicine Program, Center for Applied Medical Research (CIMA) Universidad de Navarra, CIBERONC, Madrid, Spain
- Juan Pablo Romero Riojas
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- Ainara Vallejo-Illarramendi
- 1CIBERNED-Biodonostia, Neurosciences Area, Group of Neuromuscular Diseases, San Sebastian, Spain
- Carmen Paradas
- Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Neuromuscular Disorders Unit, Sevilla, Spain
- Carmen Paradas
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
- Adolfo López de Munain
- 1CIBERNED-Biodonostia, Neurosciences Area, Group of Neuromuscular Diseases, San Sebastian, Spain
- Adolfo López de Munain
- 2Neurology Department, Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, San Sebastian, Spain
- José Antonio Páramo
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- José Antonio Páramo
- Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, CIMA Universidad de Navarra, Pamplona, Spain
- José Antonio Páramo
- Centro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain
- José Antonio Páramo
- 3Hematology Service, Clínica Universidad de Navarra, Pamplona, Spain
- Felipe Prósper
- Regenerative Medicine Program, Center for Applied Medical Research (CIMA) Universidad de Navarra, CIBERONC, Madrid, Spain
- Felipe Prósper
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- Felipe Prósper
- Laboratory of Atherothrombosis, Program of Cardiovascular Diseases, CIMA Universidad de Navarra, Pamplona, Spain
- Ana Pérez-Ruiz
- Regenerative Medicine Program, Center for Applied Medical Research (CIMA) Universidad de Navarra, CIBERONC, Madrid, Spain
- Ana Pérez-Ruiz
- Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- DOI
- https://doi.org/10.3389/fcell.2023.1128534
- Journal volume & issue
-
Vol. 11
Abstract
Aged muscles accumulate satellite cells with a striking decline response to damage. Although intrinsic defects in satellite cells themselves are the major contributors to aging-associated stem cell dysfunction, increasing evidence suggests that changes in the muscle-stem cell local microenvironment also contribute to aging. Here, we demonstrate that loss of the matrix metalloproteinase-10 (MMP-10) in young mice alters the composition of the muscle extracellular matrix (ECM), and specifically disrupts the extracellular matrix of the satellite cell niche. This situation causes premature features of aging in the satellite cells, contributing to their functional decline and a predisposition to enter senescence under proliferative pressure. Similarly, reduction of MMP-10 levels in young satellite cells from wild type animals induces a senescence response, while addition of the protease delays this program. Significantly, the effect of MMP-10 on satellite cell aging can be extended to another context of muscle wasting, muscular dystrophy. Systemic treatment of mdx dystrophic mice with MMP-10 prevents the muscle deterioration phenotype and reduces cellular damage in the satellite cells, which are normally under replicative pressure. Most importantly, MMP-10 conserves its protective effect in the satellite cell-derived myoblasts isolated from a Duchenne muscular dystrophy patient by decreasing the accumulation of damaged DNA. Hence, MMP-10 provides a previously unrecognized therapeutic opportunity to delay satellite cell aging and overcome satellite cell dysfunction in dystrophic muscles.
Keywords